Loading candles…
Amrutanjan Health Care Ltd., established in 1893, operates primarily in India as a manufacturer and seller of Ayurvedic and over-the-counter consumer healthcare products. The company, managed by the third generation of promoters, has evolved from its original focus on Ayurvedic balm for pain management into a diversified healthcare entity with business segments including pain management, women's hygiene, congestion relief, and packaged fruit juice beverages. Its product range consists of Ayurvedic balms, OTC pain management products, women's hygiene items, congestion relief products, and packaged fruit juices. Amrutanjan participates in industries such as consumer healthcare, FMCG, healthcare, and Ayurvedic formulations. Having maintained its presence in the market for more than 120 years, the company reflects a transition from a single-product firm to a broader healthcare player.
This page is a live market overview for AMRUTAJAN HEALTH LTD (AMRUTANJAN) on the NSE. As a listed security, AMRUTAJAN HEALTH LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for AMRUTANJAN before placing trades on tick2trade.
As of the latest feed, AMRUTANJAN last traded at ₹521.4 on NSE, up ₹1.4 (0.27%) from the previous close of ₹520. Today's session range is ₹515.1 – ₹526.9, against a 52-week band of ₹486 – ₹790.95. Traded volume today stands at 34.20K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for AMRUTANJAN in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether AMRUTANJAN is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for AMRUTAJAN HEALTH LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in AMRUTANJAN. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated AMRUTANJAN option chain page linked from this overview.
| Results - FY26 |
| To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 8 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and dividend | 3 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 and dividend | 10 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 12 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 15 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.